The role of senescence and immortalization in carcinogenesis
- 1 March 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 21 (3) , 477-484
- https://doi.org/10.1093/carcin/21.3.477
Abstract
Normal somatic cells are able to divide only a limited number of times before they become senescent. The occurrence of intratumoral cell death and the need for clonal evolution mean that many more cell divisions are required for tumorigenesis than is possible unless cells breach the senescence proliferation barrier and become immortalized. Senescence may therefore be a major tumor suppressor mechanism. During the past decade the study of senescence and immortalization has entered the mainstream of cancer research. A major reason for the current interest in this subject is the observation that most cancers have an activated telomere maintenance mechanism, a marker of immortalization. It has also been found that some of the most common genetic changes known to occur in cancer have a key role in the immortalization process.Keywords
This publication has 69 references indexed in Scilit:
- The serial cultivation of human diploid cell strainsPublished by Elsevier ,2004
- The limited in vitro lifetime of human diploid cell strainsPublished by Elsevier ,2004
- Microarray analysis of replicative senescenceCurrent Biology, 1999
- Replicative Senescence: An Old Lives' Tale?Cell, 1996
- Coming of age in cultureExperimental Gerontology, 1996
- A biomarker that identifies senescent human cells in culture and in aging skin in vivo.Proceedings of the National Academy of Sciences, 1995
- Origins of G1 arrest in senescent human fibroblastsBioEssays, 1995
- Senescence as a mode of tumor suppression.Environmental Health Perspectives, 1991
- Replicative Senescence: the Human Fibroblast Comes of AgeScience, 1990
- A theory of marginotomyJournal of Theoretical Biology, 1973